CHRISTINE MILLER: Open Payments
NPI 1093735417 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 8 payments from 6 companies in 2025. Trend: 2023 $2,338 · 2024 $1,780 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $242 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Janssen Biotech, Inc. | 1 | $121 |
| GlaxoSmithKline, LLC. | 2 | $52 |
| Alkermes, Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: UZEDY, RINVOQ, TREMFYA, SKYRIZI, BENLYSTA, ARISTADA, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
